Ikeda S, Kato T, Kenmotsu H, Ogura T, et al. Atezolizumab for Pretreated Non-Small Cell Lung Cancer with Idiopathic Interstitial Pneumonia: Final Analysis of Phase II AMBITIOUS Study. Oncologist 2022 Jun 27. pii: 6618634. doi: 10.1093.
PMID: 35759340